Genocury Biotech
济因生物官方网站
Shenzhen, China · Founded 2021
- Headquarters
- Shenzhen
- Founded
- 2021
- Business Model
- B2B
- Website
- genocury.com
- Last Round
- Venture RoundNov 2025
- Rounds
- 2
About
Genocury Biotech is a Shenzhen-based, R&D-driven biotechnology company developing universal in vivo cell and gene therapies for cancer, built around its proprietary Vivoexpress platform for in vivo CAR-T and CAR-NK cell engineering. In 2025 the company reported early clinical data from a China-based, academic-led in vivo CAR-T trial showing complete remission, among the first companies globally to share such in vivo CAR-T results.
Summary
Genocury Biotech is a Biotech company based in Shenzhen, China, founded in 2021. Its most recent funding was a Venture Round round in Nov 2025. Investors include GL Ventures and Capital Group.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Sign up to see all 2 rounds
Series A through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genocury-biotech"><img src="https://indexed.vc/api/badge/company/genocury-biotech" alt="Genocury Biotech on Indexed.vc" width="260" height="76" /></a>